Accéder au contenu
Merck

Pyrazinoic acid decreases the proton motive force, respiratory ATP synthesis activity, and cellular ATP levels.

Antimicrobial agents and chemotherapy (2011-08-31)
Ping Lu, Anna C Haagsma, Hoang Pham, Janneke J Maaskant, Selena Mol, Holger Lill, Dirk Bald
RÉSUMÉ

Pyrazinoic acid, the active form of the first-line antituberculosis drug pyrazinamide, decreased the proton motive force and respiratory ATP synthesis rates in subcellular mycobacterial membrane assays. Pyrazinoic acid also significantly lowered cellular ATP levels in Mycobacterium bovis BCG. These results indicate that the predominant mechanism of killing by this drug may operate by depletion of cellular ATP reserves.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Pyrazinecarboxylic acid, 99%